ABSTRACT. As study of multidrug efflux pumps is a crucial step for development of efflux pump inhibitors for treatment of Pseudomonas aeruginosa infection, the objective of this study was to examine the contribution of the MexXY multidrug efflux systems and other chromosomal mechanisms in aminoglycoside (AMG) resistance in P. aeruginosa isolated from dogs and cats. Thirteen Pseudomonas aeruginosa isolates from canine and feline infections were examined for contribution of the MexXY multidrug efflux pump and four other chromosomally-encoded genes including PA5471, galU, nuoG and rplY to AMG resistance. All the isolates were resistant to multiple AMGs and expressed mexXY. Deletion of mexXY caused 2-to 16-fold reduction in AMG MICs. Overproduction of MexXY did not fully account for the observed AMG resistance. No good correlations were detected between MexXY transcription level and AMG MICs. While no mutations were found in mexZ, PA5471 expression varied and its impact on MexXY expression and AMG resistance is diverse. No mutations were found in galU. Only two isolates carried a single base change G-367-T in rplY. Complete transcription of nuoG was detected in all the isolates. In conclusion, the MexXY multidrug efflux pump plays a role in AMG resistance in the dog and cat P. aeruginosa isolates, while disruption of nuoG, rplY and galU did not have a significant impact. These results indicate the existence of uncharacterized AMG-resistance mechanisms. Pseudomonas aeruginosa is infamously known as a common cause of chronic and recurrent infections in both humans and animals, of which the most-notably diseases in dogs and cats include otitis externa/media, urinary tract infection and pyoderma [9,10,20]. Treatment of P. aeruginosa infection is challenging, because the pathogen intrinsically exhibits and efficiently develops high resistance to several antimicrobials structurally and functionally unrelated, leading to multidrug resistance [1,24].As many antipseudomonal drugs are available for therapeutic use in dogs and cats, aminoglycosides (AMGs) are considered a vital component of antipseudomonal chemotherapy [22] due to their efficacy, safety and reasonable price. However, panaminoglycoside resistance e.g., gentamicin, spectinomycin, streptomycin and amikacin has been increasingly reported in the P. aeruginosa dog and cat isolates [18,19,23]. Such resistance has been clarified to be predominantly due to a poorly understood mechanism namely "impermeability resistance" as a consequence of diminished drug uptake and/or accumulation [21,31]. The MexXY efflux system, a multidrug efflux pump in the resistance-nodulation-cell-division (RND) family, is involved in the reduced level of AMG accumulation implicated in both impermeability-type and adaptive-type AMG resistance [12,21,22]. The MexXY efflux pump is encoded by the mexXY operon and evidently serves as the major AMG-resistance mediating system in P. aeruginosa clinical isolates. This system additionally confers resistance to nonaminoglycosides, including tetracycline...